Ototoxicity Completed Phase 2 Trials for Ginkgo biloba (DB01381)

Also known as: Auditory toxicity / Ototoxicity (disorder)

IndicationStatusPhase
DBCOND0008838 (Ototoxicity)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01139281The Protective Effect of Ginkgo Biloba Extract on Cisplatin-induced Ototoxicity in HumansPrevention